Results 91 to 100 of about 30,428 (253)

Intravenous flurbiprofen for post-thymectomy pain relief in patients with myasthenia gravis

open access: yesJournal of Cardiothoracic Surgery, 2012
Background Post-thymectomy pain in myasthenia gravis (MG) patients can inhibit breathing and coughing. Inappropriate usage of analgesics may exacerbate respiratory inhibition and even cause myasthenic crisis.
Su Chunhua   +6 more
doaj   +1 more source

Efficacy and Safety of Efgartigimod for Patients With Myasthenia Gravis in a Real‐World Cohort of 77 Patients

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 4, April 2025.
This real‐world study of 77 myasthenia gravis (MG) patients treated with efgartigimod showed rapid symptom improvement across disease severities. Sustained efficacy was achieved with repeated cycles, positioning efgartigimod as a promising MG therapy combining swift response and durable maintenance benefits. ABSTRACT Aims Efgartigimod, a first‐in‐class
Sijia Hao   +12 more
wiley   +1 more source

Neonatal thymectomy reveals differentiation and plasticity within human naive T cells.

open access: yesJournal of Clinical Investigation, 2016
The generation of naive T cells is dependent on thymic output, but in adults, the naive T cell pool is primarily maintained by peripheral proliferation.
T. van den Broek   +11 more
semanticscholar   +1 more source

Videotorakoskoopiline tümektoomia müasteenia ravis [PDF]

open access: yes, 2009
Müasteenia on krooniline autoimmuunhaigus skeletilihaste progresseeruva nõrkuse ja kiire väsimisega füüsilisel koormusel. Üheks müasteenia ravivõimaluseks on videotorakoskoopiline tümektoomia, mis on minimaalinvasiivne ravimeetod.
Laisaar, Tanel   +3 more
core   +2 more sources

Thoracoscopic Thymectomy Using a Subxiphoid Approach for Anterior Mediastinal Tumors.

open access: yesAnnals of Thoracic and Cardiovascular Surgery, 2018
PURPOSE Video-assisted thoracic surgery (VATS) techniques have been widely used for resection of mediastinal tumors. This study investigated the usefulness of the subxiphoid approach in thoracoscopic thymectomy.
H. Numanami   +6 more
semanticscholar   +1 more source

Malignant lymphomas in transplantation patients: a review of the world experience. [PDF]

open access: yes, 1970
Malignant lymphomas developed in 9 renal homograft recipients treated at widely separated transplantation centers. The development of these tumors appears to be an indirect complication of organ transplantation and/or the measures taken to prevent ...
Penn, I, Starzl, TE
core  

An update on treatments in myasthenia gravis [PDF]

open access: yes, 2017
This month, we discuss three papers which publish the results of trials into potential treatment approaches to myasthenia gravis (MG). When treatment with cholinesterase inhibitors alone fails to control symptoms, treatment with steroids may be required,
Jones, Lliwen, Robertson, Neil
core   +1 more source

Venous thromboembolism after adult thymus or thymic tumor resection: A single‐center experience

open access: yesThoracic Cancer, 2020
Background Venous thromboembolism (VTE) is a common postoperative complication. Previous studies have shown that the VTE incidence after major thoracic surgery is high. However, there have been no exclusive data after thymectomy thus far.
Xingguo Yang   +8 more
doaj   +1 more source

MSCs Suppress Macrophage Necroptosis and Foster Liver Regeneration by Modulating SP1/SK1 Axis in Treating Acute Severe Autoimmune Hepatitis

open access: yesAdvanced Science, Volume 12, Issue 12, March 27, 2025.
In AS‐AIH, the SP1/SK1/S1P axis and S1P/S1PR2/YAP pathway are central to disease progression and liver regeneration. MSCs can enhance liver repair by promoting S1P synthesis, then inhibiting necroptosis, offering a potential therapeutic strategy for AS‐AIH.
Ran An   +5 more
wiley   +1 more source

Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center

open access: yesMuscle &Nerve, Volume 71, Issue 3, Page 422-428, March 2025.
ABSTRACT Introduction/Aims Neonatal Fc receptor (FcRn) inhibitors represent a promising treatment option for patients with generalized myasthenia gravis (gMG); however, data on clinical use are limited. The aim of this report is to describe one center's approach to efgartigimod dosing in patients with gMG.
Nicholas J. Silvestri
wiley   +1 more source

Home - About - Disclaimer - Privacy